Merge PACS vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Merative
VS
by iRhythm Technologies, Inc.

AI Verdict

Merge PACS is an enterprise imaging solution focused on managing and integrating AI for various diagnostic images, including those in cardiology. In contrast, the Zio AT ECG Monitoring System is a wearable device and service dedicated to continuous, AI-powered ECG monitoring for arrhythmia detection. While both leverage AI in cardiology, Merge PACS optimizes imaging workflows, while Zio AT provides remote physiological monitoring for rhythm disorders.

Choose Merge PACS if…

Choose Merge PACS if your multi-site health system requires an enterprise-level solution to consolidate diverse imaging data, streamline radiology workflows, and integrate AI insights across multiple specialties. This tool is ideal for organizations seeking flexible deployment options (on-premise, cloud, hybrid) and enhanced diagnostic capabilities for a high volume of imaging studies.

View Merge PACS →

Choose Zio AT ECG Monitoring System if…

Choose the Zio AT ECG Monitoring System if you need a reliable, wearable solution for continuous, long-term (up to 14 days) ECG monitoring to detect symptomatic and asymptomatic arrhythmias. This system is best suited for cardiologists and healthcare providers looking for an FDA-cleared, AI-powered service that provides comprehensive reports for arrhythmia diagnosis and patient management.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Merge PACS Zio AT ECG Monitoring System
Pricing Contact vendor Contact for pricing
Deployment On-premise, Cloud, Hybrid Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

Zio AT's wearable patch and patient-centric design offer superior usability for patients, leading to high compliance and comfort during extended monitoring. While Merge PACS focuses on streamlining complex clinician workflows within an imaging environment, Zio AT's ease of use for both patients and clinicians in its specific domain gives it an edge in overall accessibility and patient experience.

Clinical Value

Zio AT ECG Monitoring System

Zio AT offers direct, evidence-backed clinical value through its FDA-cleared AI algorithm for continuous arrhythmia detection, which has been shown to improve diagnostic yield and patient outcomes compared to traditional methods. Clinical studies demonstrate its effectiveness in detecting actionable arrhythmias that might be missed by shorter monitoring.

Pricing & Value

Zio AT ECG Monitoring System

Although both tools have opaque pricing, Zio AT has published studies demonstrating its cost-effectiveness and health economic value, showing reductions in outpatient visits, repeat testing, and potential savings in downstream procedures. Merge PACS lacks publicly available data on its cost-effectiveness or return on investment, making it difficult to assess its value beyond its features.

Enterprise Readiness

Merge PACS

Merge PACS is explicitly designed as an 'enterprise-level' PACS for multi-site health systems, offering flexible deployment options (on-premise, cloud, hybrid) and extensive integration with EMR/EHR, RIS, HIS, and VNA systems. Its proven adoption by large healthcare systems and broad feature set for imaging management make it more broadly enterprise-ready than Zio AT, which is specialized for cardiac monitoring.

Innovation

Zio AT ECG Monitoring System

Zio AT's innovation lies in its novel wearable patch technology combined with an FDA-cleared, deep-learned AI algorithm for continuous, long-term cardiac monitoring, which fundamentally changes how arrhythmias are detected. This represents a more disruptive innovation in patient monitoring and diagnosis compared to Merge PACS's valuable, but more platform-oriented, AI integration capabilities.

Support & Docs

Tie

Both companies appear to offer comprehensive support, including implementation, training, and ongoing technical assistance. Merative highlights 24/7 support and extensive documentation like DICOM conformance statements, while iRhythm provides dedicated customer care, patient support resources, and a robust clinical resource center. Without more detailed comparative metrics on response times, issue resolution, or user satisfaction for both, it's difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Merge PACS Zio AT ECG Monitoring System
Tool Name Merge PACS Zio AT ECG Monitoring System
Primary System Type Enterprise-level Picture Archiving and Communication System (PACS) Wearable Mobile Cardiac Telemetry (MCT) System
Company Merative iRhythm Technologies, Inc.
Primary Clinical Specialties Cardiology, Radiology Cardiology
Core AI Functionality AI integration and readiness (single worklist access to 3rd party AI applications) FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection
Key Monitoring/Management Aspect Enterprise-wide image management and consolidation, enhanced diagnostic workflows Continuous, uninterrupted ECG recording for up to 14 days, real-time data transmission

Videos

Demos, reviews, and walkthroughs featuring Merge PACS and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Merge PACS is an enterprise-level Picture Archiving and Communication System (PACS) designed to streamline radiology workflows, consolidate imaging data, and support multi-modality diagnostic interpretation for specialties like Radiology and Cardiology. In contrast, the Zio AT ECG Monitoring System is a wearable mobile cardiac telemetry (MCT) service focused on continuous, AI-powered ECG monitoring for long-term arrhythmia detection, primarily serving Cardiology specialists.
Merge PACS is 'AI ready' and facilitates AI integration by providing single worklist access to third-party AI applications, enhancing diagnostic workflows. The Zio AT ECG Monitoring System, on the other hand, utilizes its own FDA-cleared deep-learned AI algorithm (ZEUS System) specifically for arrhythmia detection from continuous ECG recordings.
Merge PACS manages enterprise-wide imaging data from multiple modalities (e.g., CT, MR, PET) and provides secure web-based access for remote reading, along with integration with EMR/EHR, RIS, HIS, and VNA systems. The Zio AT system records continuous ECG data via a wearable patch and wireless gateway, with clinicians accessing comprehensive end-of-wear reports through the ZioSuiteu00ae clinician portal and mobile app.
Merge PACS primarily focuses on clinician workflows and enterprise image management, offering secure web-based access for remote reading by physicians. The Zio AT ECG Monitoring System includes a wearable Zio AT patch for continuous ECG recording and a MyZiou00ae patient mobile app for symptom logging and education.
Merge PACS supports a broader range of specialties, including Radiology, Cardiology, and general Enterprise Imaging, with customizable worklists for multiple specialties. The Zio AT ECG Monitoring System is specifically designed for Cardiology, focusing on long-term cardiac arrhythmia detection.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.